ubmslateRN-logo-ubm

RN Mobile Menu

Topics:

Rheumatology Network

King vs. Burwell: What it Means for Your Patients

What are the implications of the Supreme Court's decision for patients with rheumatic disease?

 

©thailoei92/shutterstock.com

Recent Content

The news from phase 3 trials of psoriatic arthritis treatments is upbeat: certolizumab pegol (Cimzia), apremilast (Otezla), and secukinumab (Cosentyx) all continue to show positive effects.

The goal of 90% skin clearance is “reachable” for many patients with severe psoriasis with interleukin-17 (IL-17) inhibitors. A closer look here.

There is now clinical evidence to support cyclosporine and prednisolone as first line options in the treatment of pyoderma gangrenosum.

Intensive treatment with statins may help reduce risk of cardiovascular events in patients with inflammatory arthritis, suggests a new study.

©The Len/shutterstock.com

How do NSAIDS stack up to COX inhibitors and glucocortocoids in acute gout? This article summarizes a Cochrane review of 23 trials involving 2200 patients.

©eye for photos/shutterstock.com

A review of ischemic optic neuropathies--arteritic and nonarteritic.

©Blan-k/shutterstock.com

How do patients with rheumatoid arthritis rate their health and well being? Their relationship with their physician? Two new surveys shed light.

By clicking Accept, you agree to become a member of the UBM Medica Community.